Patent · US Expired

Synthetic antigens for the detection of antibodies to hepatitis C virus

US6872520B2 · kind B2 · utility

0Cited by

7References

26Claims

0Family size

Assignee

Innogenetics N.V. · BE

Inventors

Robert Deleys · Grimbergen, BE
Dirk Pollet · Schilde, BE
Geert Maertens · Brugge, BE
Hugo Van Heuverswijn · Laarne, BE

Key dates

Filing date	Jan 15, 2002
Grant date	Mar 29, 2005
Priority date	—
Expiry date	Jun 22, 2022

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/826
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Peptide sequences are provided which are capable of mimicking proteins encoded by HCV for use as reagents for screening of blood and blood products for prior exposure to HCV. The peptides are at least 5 amino acids long and can be used in various specific assays for the detection of antibodies to HCV, for the detection of HCV antigens, or as immunogens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.